Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pipeline Setback for Glaxo
Yahoo/Zacks
Thursday, December 15, 2011 - 7:14pm
tags:
GSK, Tykerb, breast cancer
Amgen CEO to Retire
Barron's
Thursday, December 15, 2011 - 7:12pm
tags:
Amgen, Kevin Sharer, Pharma CEOs
Flamel Shares Flamed Out: What You Need to Know
Motley Fool
Thursday, December 15, 2011 - 7:11pm
tags:
Flamel, GSK, Novartis, Emisphere
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thursday, December 15, 2011 - 12:08pm
tags:
cancer, Antigenics, Amgen, Bristol-Myers Squibb, Celgene, Dendreon, Generex, Merck KGaA, GSK, Idera Pharmaceuticals, NewLink Genetics, Novartis, Roche, Oncothyreon, Transgene, Vical
Cephalon, Acusphere Claim Celgene’s Abraxane Infringes Patent
Bloomberg
Thursday, December 15, 2011 - 12:04pm
tags:
Acusphere, Celgene, Abraxane, Cephalon, breast cancer
Gilenya trial could ease safety worries
Baltimore Sun, MD
Thursday, December 15, 2011 - 11:35am
tags:
MS, multiple sclerosis, Gilenya, Novartis
Hospitals Adopt Drug Industry Sales Strategy
Kaiser Health News
Thursday, December 15, 2011 - 11:33am
tags:
hospitals
Vertex Names Jeff Leiden as New CEO, Staring Down Tough New Competition
Xconomy
Thursday, December 15, 2011 - 11:31am
tags:
Jeff Leiden, Vertex, Pharma CEOs
Covidien to spin off pharma biz
Fierce Pharma
Thursday, December 15, 2011 - 11:04am
tags:
spinoff, Covidien
FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis
Yahoo
Thursday, December 15, 2011 - 11:02am
tags:
FDA, Kalydeco, Vertex, VX-770, cystic fibrosis
Germany gives final OK to AstraZeneca heart drug
Reuters
Thursday, December 15, 2011 - 10:59am
tags:
Germany, AstraZeneca, Brilinta
Pharma Gets More Time To Record Gifts To Docs
Pharmalot
Thursday, December 15, 2011 - 9:47am
tags:
physician gifts
Chelsea Therapeutics gets patent protection on hypotension drug
Reuters
Thursday, December 15, 2011 - 9:46am
tags:
Chelsea Therapeutics, hypotension, Northera, neurogenic orthostatic hypotension, Parkinson's Disease
Isis Adds Three New Drugs to Its Development Pipeline
Yahoo
Thursday, December 15, 2011 - 9:45am
tags:
Isis Pharmaceuticals, ISIS-FVIIRx, ISIS-DGAT2Rx, ISIS-APOARx, nonalcoholic steatohepatitis, thrombotic diseases, atherosclerosis
MAP's Levadex: Blockbuster Potential With A March 26 PDUFA Date
Seeking Alpha
Thursday, December 15, 2011 - 9:39am
tags:
Levadex, MAP Pharmaceuticals, FDA, migraines
Ampio Pharmaceuticals: The Unanswered Questions
Seeking Alpha
Thursday, December 15, 2011 - 9:38am
tags:
Ampio, Zertane, Optina, Ampion
Pfizer Settled About Half of Prempro Cases, Adds to Reserve
Bloomberg
Thursday, December 15, 2011 - 9:37am
tags:
Pfizer, settlements, Wyeth, Prempro, HRT
Fat-Burning Roche Medicine Stops Diabetes in Mice Study, Researchers Say
Bloomberg
Wednesday, December 14, 2011 - 6:44pm
tags:
Roche, diabetes, FGF21
Spectrum Turns Neglected Cancer Drugs Into Cash Cows
Investors.com
Wednesday, December 14, 2011 - 6:43pm
tags:
Spectrum Pharmaceuticals, cancer, Fusilev, Zevalin
BioSante’s Female Desire Drug Fails to Boost Libido in Late-Stage Studies
Bloomberg
Wednesday, December 14, 2011 - 6:41pm
tags:
BioSante, female sexual dysfunction, LibiGel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.